Evidence map›Paper›PMID 37425995›Full record

ArticleFrontiers in microbiology2023

Long-term prevalence follow-up (1967-2022) of HTLV-2 among vulnerable indigenous populations in the Amazon region of Brazil.

Ricardo Ishak, Marluísa de Oliveira Guimarães Ishak, Isabella Nogueira Abreu, Luiz Fernando Almeida Machado, Sandra Souza Lima, Maria Alice Freitas Queiroz, Izaura Maria Cayres-Vallinoto, João Farias Guerreiro, Antonio Carlos Rosário Vallinoto

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Observational
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Ricardo IshakLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém, Pará, Brazil.
Marluísa de Oliveira Guimarães IshakLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém, Pará, Brazil.
Isabella Nogueira AbreuLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém, Pará, Brazil.
Luiz Fernando Almeida MachadoLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém, Pará, Brazil.
Sandra Souza LimaLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém, Pará, Brazil.
Maria Alice Freitas QueirozLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém, Pará, Brazil.
Izaura Maria Cayres-VallinotoLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém, Pará, Brazil.
João Farias GuerreiroLaboratory of Human and Medical Genetics, Institute of Biological Sciences, Federal University of Pará, Belem, Pará, Brazil.
Antonio Carlos Rosário VallinotoLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém, Pará, Brazil.
Universidade Federal do Pará · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Human T-lymphotropic virus 2 (HTLV-2) has been described for more than 30 years as an endemic infection in Brazilian indigenous populations, with its occurrence varying by age and sex, maintained mainly by sexual intercourse and mother-to-child transmission, favoring intrafamilial aggregation. Methods: The epidemiological scenario of HTLV-2 infection has been described among communities of the Amazon region of Brazil (ARB), with the number of retrospective positive blood samples increasing for more than 50 years. Results: Five publications were selected that showed the presence of HTLV-2 in 24 of 41 communities; the prevalence of infection was described among 5,429 individuals at five points in time. Among the Kayapó villages, the prevalence rates were described according to age and sex and reached up to 41.2%. Three communities (Asurini, Araweté, and Kaapor) were kept virus free for 27 to 38 years of surveillance. Low, medium and high prevalence levels of infection were defined, and two pockets of high endemicity were shown in the state of Pará, pointing to the Kikretum and Kubenkokrê Kayapó villages as the epicenter of HTLV-2 in the ARB. Discussion: The prevalence rates over the years have shown a decline among the Kayapó (from 37.8 to 18.4%) and an apparent change to a higher prevalence among females, but not during the first decade of life, usually associated with transmission from mother to child. Sociocultural and behavioral aspects, as well as public health policies directed toward sexually transmitted infections, might have positively influenced the decline in HTLV-2 infections.

Indexed as

AmazonepidemiologyHTLV-1/2indigenousvulnerable population

Identifiers

PMID37425995
PMCPMC10324662
OpenAlexW4381733311

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.